Thu, April 26, 2012
Wed, April 25, 2012
Tue, April 24, 2012
Mon, April 23, 2012
Sun, April 22, 2012
Sat, April 21, 2012
Fri, April 20, 2012
Thu, April 19, 2012
Wed, April 18, 2012
Tue, April 17, 2012
Mon, April 16, 2012
Sun, April 15, 2012
[ Sun, Apr 15th 2012 ] - Market Wire
DaVita Announces CFO Transition
Sat, April 14, 2012
Fri, April 13, 2012

Thoratec Schedules First Quarter Conference Call, Webcast


//health-fitness.news-articles.net/content/2012/ .. dules-first-quarter-conference-call-webcast.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


Thoratec Schedules First Quarter Conference Call, Webcast -- PLEASANTON, Calif., April 20, 2012 /PRNewswire/ --

Thoratec Schedules First Quarter Conference Call, Webcast

[ ]

PLEASANTON, Calif., April 20, 2012 /PRNewswire/ -- Thoratec Corporation (NASDAQ: [ THOR ]), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the first quarter of fiscal year 2012 on Tuesday, May 1.

The company will hold a conference call to discuss its financial results and operating activities, open to all interested parties, at 1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern Daylight Time), Tuesday, May 1, hosted by Gary F. Burbach, President and Chief Executive Officer.

The teleconference can be accessed by calling (719) 457-2620, passcode 8806446. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will be available on the Internet at [ http://edge.media-server.com/m/p/otq2n4qy/lan/en ], or [ http://www.thoratec.com ].

A replay of the conference call will be available through Tuesday, May 8, via [ http://www.thoratec.com ], or by telephone at (719) 457-0820, passcode 8806446.

Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's products include the HeartMate® LVAS (Left Ventricular Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than 18,000 devices implanted in patients suffering from heart failure. Thoratec also manufactures and distributes the CentriMag® and PediMag®/PediVAS® product lines. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's website at [ http://www.thoratec.com ].

Thoratec, the Thoratec logo, HeartMate, HeartMate II and GoGear are registered trademarks of Thoratec Corporation. CentriMag and PediMag are registered trademarks of Thoratec LLC, and PediVAS is a registered trademark of Thoratec Switzerland GmbH.

SOURCE Thoratec Corporation

[ Back to top ]

RELATED LINKS
[ http://www.thoratec.com ]


Publication Contributing Sources